These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 9417294)

  • 1. [Wilms' tumor: reached progress and future prospects].
    Tamaro P
    Arch Ital Urol Androl; 1997 Sep; 69(4):227-32. PubMed ID: 9417294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilms' tumour. Optimal treatment strategies.
    Suryanarayan K; Marina N
    Drugs; 1998 Oct; 56(4):598-605. PubMed ID: 9806106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of treatment for Wilms tumor.
    Green DM
    J Pediatr Surg; 2013 Jan; 48(1):14-9. PubMed ID: 23331787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
    Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
    J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms' tumor 1991. Clinical evaluation and treatment.
    Exelby PR
    Urol Clin North Am; 1991 Aug; 18(3):589-97. PubMed ID: 1652172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: a report from the National Wilms' Tumor Study.
    Green DM; Breslow NE; Beckwith JB; Takashima J; Kelalis P; D'Angio GJ
    J Clin Oncol; 1993 Jan; 11(1):91-5. PubMed ID: 8380295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001.
    Pianezza ML; Rubin S; Bass J; Chou S; Pike JG; Leonard MP
    Can J Urol; 2004 Feb; 11(1):2151-6. PubMed ID: 15003157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of Wilms' tumor trial (WT-99) in Shanghai children's medical center].
    Tang JY; Pan C; Xu M; Xue HL; Chen J; Zhao HL; Gu LL; Wang YP
    Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):131-4. PubMed ID: 14759320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Wilms' tumour. Current recommendations.
    Mehta MP; Bastin KT; Wiersma SR
    Drugs; 1991 Nov; 42(5):766-80. PubMed ID: 1723373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
    Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
    J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 23-year experience with malignant renal tumors in infancy and childhood.
    Tröbs RB; Hänsel M; Friedrich T; Bennek J
    Eur J Pediatr Surg; 2001 Apr; 11(2):92-8. PubMed ID: 11371043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-based management: current concepts of treating malignant solid tumors of childhood.
    Grosfeld JL
    J Am Coll Surg; 1999 Oct; 189(4):407-25. PubMed ID: 10509467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study.
    Grundy P; Breslow N; Green DM; Sharples K; Evans A; D'Angio GJ
    J Clin Oncol; 1989 May; 7(5):638-47. PubMed ID: 2540289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of Wilms tumor. Results of the National Wilms Tumor Studies.
    Green DM; Thomas PR; Shochat S
    Hematol Oncol Clin North Am; 1995 Dec; 9(6):1267-74. PubMed ID: 8591964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric genitourinary tumors.
    Castellino SM; McLean TW
    Curr Opin Oncol; 2007 May; 19(3):248-53. PubMed ID: 17414644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapy for Wilms' tumor.
    Metzger ML; Dome JS
    Oncologist; 2005; 10(10):815-26. PubMed ID: 16314292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.